Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manfred P Wirth

Showing results (211-220 of 272) with videos related to

Pageof 28
Sort By:
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Cancer Investigation|January 8, 2011
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma, Thomas Weber, Matthias Meinhardt, et al.
Cancers|September 10, 2021
Increased Sensitivity of Detection of <i>RASSF1A</i> and <i>GSTP1</i> DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCRMarkus Friedemann, Friederike Horn, Katharina Gutewort, et al.
European Urology|July 22, 2015
Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk AnalysisMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Anticancer Research|August 30, 2008
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cellsDoreen Kunze, Daniela Wuttig, Susanne Fuessel, et al.
European Urology|August 24, 2014
Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomyMichael Froehner, Vladimir Novotny, Ulrike Heberling, et al.
International Journal of Oncology|June 7, 2003
Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCRSusanne Fuessel, Denise Sickert, Axel Meye, et al.
International Journal of Cancer|October 29, 2002
Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patientsAndrea Kiessling, Marc Schmitz, Stefan Stevanovic, et al.
Urologia Internationalis|March 29, 2002
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumorsPanagiotis Tsatalpas, Bettina Beuthien-Baumann, Joachim Kropp, et al.
The Prostate|August 22, 2006
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt, Susanne Fuessel, Rainer Koch, et al.
Pageof 28

Showing results (211-220 of 272) with videos related to

Sort By:
Pageof 28
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Cancer Investigation|January 8, 2011
Expression of the Forkhead transcription factor FOXP1 is associated with tumor grade and Ki67 expression in clear cell renal cell carcinomaMarieta I Toma, Thomas Weber, Matthias Meinhardt, et al.
Cancers|September 10, 2021
Increased Sensitivity of Detection of <i>RASSF1A</i> and <i>GSTP1</i> DNA Fragments in Serum of Prostate Cancer Patients: Optimisation of Diagnostics Using OBBPA-ddPCRMarkus Friedemann, Friederike Horn, Katharina Gutewort, et al.
European Urology|July 22, 2015
Decreased Overall and Bladder Cancer-Specific Mortality with Adjuvant Chemotherapy After Radical Cystectomy: Multivariable Competing Risk AnalysisMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Anticancer Research|August 30, 2008
Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cellsDoreen Kunze, Daniela Wuttig, Susanne Fuessel, et al.
European Urology|August 24, 2014
Relationship of the number of removed lymph nodes to bladder cancer and competing mortality after radical cystectomyMichael Froehner, Vladimir Novotny, Ulrike Heberling, et al.
International Journal of Oncology|June 7, 2003
Multiple tumor marker analyses (PSA, hK2, PSCA, trp-p8) in primary prostate cancers using quantitative RT-PCRSusanne Fuessel, Denise Sickert, Axel Meye, et al.
International Journal of Cancer|October 29, 2002
Prostate stem cell antigen: Identification of immunogenic peptides and assessment of reactive CD8+ T cells in prostate cancer patientsAndrea Kiessling, Marc Schmitz, Stefan Stevanovic, et al.
Urologia Internationalis|March 29, 2002
Diagnostic value of 18F-FDG positron emission tomography for detection and treatment control of malignant germ cell tumorsPanagiotis Tsatalpas, Bettina Beuthien-Baumann, Joachim Kropp, et al.
The Prostate|August 22, 2006
Quantitative multi-gene expression profiling of primary prostate cancerUta Schmidt, Susanne Fuessel, Rainer Koch, et al.
Pageof 28